Cleared Traditional

K093489 - IN VISION-PLUS NANO WITH NEUTRAL ADVANTAGE TECHNOLOGY

K093489 is an FDA 510(k) clearance for IN VISION-PLUS NANO WITH NEUTRAL ADVANT..., manufactured by Rymed Technologies, Inc.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 261-day FDA review.

K093489 · Rymed Technologies, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2010
Decision
261d
Days
Class 2
Risk

K093489 is an FDA 510(k) clearance for the IN VISION-PLUS NANO WITH NEUTRAL ADVANTAGE TECHNOLOGY. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Rymed Technologies, Inc. (Shelton, US). The FDA issued a Cleared decision on July 29, 2010 after a review of 261 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Rymed Technologies, Inc. devices

FDA 510(k) Submission Details - K093489

510(k) Number K093489 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 10, 2009
Decision Date July 29, 2010
Days to Decision 261 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
132d slower than avg
Panel avg: 129d · This submission: 261d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 647
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K093489.
HOSPIRA INFUSION BLOOD SETS
K101677 · Hospira, Inc. · Aug 2010
GRIPPER MICRO BLUNT CANNULA, NON-CORING SAFETY NEEDLE (GRIPPER MICRO NEEDLE) MODEL: 21-3253-24, 21-3258-24, 21-3262-24,
K101180 · Smiths Medical MD, Inc. · Aug 2010
INTRAVSCULAR ADMINISTRATION SET
K100946 · Terumo Europe N.V. · Aug 2010
POLYFIN INFUSION SET, MODELS MMT-165, MMT-365, MMT-366, MMT-312S AND MMT-312L AND SOF-SET INFUSION SETS
K100432 · Medtronic Minimed · Jul 2010
CLAVE NEUTRON
K100434 · Icu Medical, Inc. · Jul 2010
DUAL LUER LOCK CAP, MODEL 2C6250
K101385 · Baxter Healthcare Corp · Jun 2010